SRS10547892 SAMN22245961 GSM5624376 PT16_DX_Control_1 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT16 timepoint DX treatment Control cell type Live human CD45+ or Live human CD45+GFPlow SRS10547893 SAMN22245891 GSM5624377 PT16_DX_Control_2 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT16 timepoint DX treatment Control cell type Live human CD45+ or Live human CD45+GFPlow SRS10547894 SAMN22245934 GSM5624378 PT16_DX_Treated_1 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT16 timepoint DX treatment Treated cell type Live human CD45+ or Live human CD45+GFPlow SRS10547895 SAMN22245936 GSM5624380 PT03_REL_Treated_1 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT03 timepoint REL treatment Treated cell type Live human CD45+ or Live human CD45+GFPlow SRS10547896 SAMN22245935 GSM5624379 PT16_DX_Treated_2 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT16 timepoint DX treatment Treated cell type Live human CD45+ or Live human CD45+GFPlow SRS10547897 SAMN22245937 GSM5624381 PT03_REL_Treated_2 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT03 timepoint REL treatment Treated cell type Live human CD45+ or Live human CD45+GFPlow SRS10547898 SAMN22245938 GSM5624382 PT03_REL_Control_1 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT03 timepoint REL treatment Control cell type Live human CD45+ or Live human CD45+GFPlow SRS10547899 SAMN22245939 GSM5624383 PT03_REL_Control_2 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT03 timepoint REL treatment Control cell type Live human CD45+ or Live human CD45+GFPlow SRS10547900 SAMN22245940 GSM5624384 PT15_DX_Control_1 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT15 timepoint DX treatment Control cell type Live human CD45+ or Live human CD45+GFPlow SRS10547901 SAMN22245941 GSM5624385 PT15_DX_Control_2 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT15 timepoint DX treatment Control cell type Live human CD45+ or Live human CD45+GFPlow SRS10547902 SAMN22245942 GSM5624386 PT15_DX_Treated_1 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT15 timepoint DX treatment Treated cell type Live human CD45+ or Live human CD45+GFPlow SRS10547903 SAMN22245943 GSM5624387 PT15_DX_Treated_2 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT15 timepoint DX treatment Treated cell type Live human CD45+ or Live human CD45+GFPlow SRS10547904 SAMN22245944 GSM5624388 PT01_DX_Treated_1 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT01 timepoint DX treatment Treated cell type Live human CD45+ or Live human CD45+GFPlow SRS10547905 SAMN22245945 GSM5624389 PT01_DX_Treated_2 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT01 timepoint DX treatment Treated cell type Live human CD45+ or Live human CD45+GFPlow SRS10547906 SAMN22245946 GSM5624390 PT01_DX_Control_1 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT01 timepoint DX treatment Control cell type Live human CD45+ or Live human CD45+GFPlow SRS10547907 SAMN22245947 GSM5624391 PT01_DX_Control_2 9606 Homo sapiens bioproject 770973 source_name Xenograft BMMC disease state acute myeloid leukemia (AML) patient id PT01 timepoint DX treatment Control cell type Live human CD45+ or Live human CD45+GFPlow